Replies to post #796648 on NorthWest Biotherapeutics Inc (NWBO)

[seekinganswers]

BagHolder Hall Of Fame. Bravo
Zero chance you were a Merrill Lynch analyst or have 50 years experience...
JMHO

[beartrap12]

Maverick_1, I'm glad to hear you say this:

A BUYOUT does NOT even pass my SMELL TEST!

Also, I gather you don't believe a hostile takeover is possible, though please correct me if I misinterpreted what you've said. I remember reading (I believe in the incorporation papers? maybe) that Linda made it virtually impossible for anyone or any group to conduct a hostile takeover.

Most FUDsters on iHub would have us believe that our CEO Linda Powers has no experience and cannot protect the company from predators. Quite the opposite and she's using her knowledge to safeguard our investment in DCVax.
Here's her abbreviated resume, which can be found on NWBO's website:

Ms. Powers has served as the Chairman of NW Bio since 2007, and as CEO since 2011. Ms. Powers previously served as a Managing Director of Toucan Capital Fund II, an investment fund focused on regenerative medicine and immune therapies, from 2001 to 2010. In addition, she has over 15 years’ experience in corporate finance and restructurings, mergers and acquisitions, joint ventures and intellectual property licensing. Ms. Powers has served for many years on a number of boards and commissions, including M2GEN (an affiliate of Moffitt Cancer Center), the Chinese Biopharmaceutical Association, the Rosalind Franklin Society, the Maryland Stem Cell Research Commission, a Steering Committee of the National Academy of Sciences evaluating government research funding, and three Governors’ commissions focused on building biotech and other industries. Ms. Powers taught for more than six years at the National Institutes of Health, on medical product development and commercialization, and at Georgetown Law School as an adjunct professor. Ms. Powers serves on the boards of a number of private biotechnology companies. Ms. Powers holds a B.A. from Princeton University, magna cum laude, and a J.D. from Harvard Law School, magna cum laude.

It doesn't even get into her experience with writing strong patents.

Based on her "15 years experience in corporate finance and restructurings, mergers and acquistion, joint ventures", and the exceptional moves we've seen her make to date protecting NWBO from Wall Street vultures, I expect her to put together a bullet-proof partnership/franchise/joint venture...whatever it takes, to move DCVax ahead and to the head of the crowded Pharma field.